These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

794 related items for PubMed ID: 29986744

  • 1. Protein phosphatase 2A activation mechanism contributes to JS-K induced caspase-dependent apoptosis in human hepatocellular carcinoma cells.
    Liu L, Huang Z, Chen J, Wang J, Wang S.
    J Exp Clin Cancer Res; 2018 Jul 09; 37(1):142. PubMed ID: 29986744
    [Abstract] [Full Text] [Related]

  • 2. Protein phosphatase 2A mediates JS-K-induced apoptosis by affecting Bcl-2 family proteins in human hepatocellular carcinoma HepG2 cells.
    Liu L, Huang Z, Chen J, Wang J, Wang S.
    J Cell Biochem; 2018 Aug 09; 119(8):6633-6643. PubMed ID: 29693750
    [Abstract] [Full Text] [Related]

  • 3. The Nitric Oxide Prodrug JS-K Induces Ca(2+)-Mediated Apoptosis in Human Hepatocellular Carcinoma HepG2 Cells.
    Liu L, Wang D, Wang J, Wang S.
    J Biochem Mol Toxicol; 2016 Apr 09; 30(4):192-9. PubMed ID: 26616367
    [Abstract] [Full Text] [Related]

  • 4. JS-K, a nitric oxide prodrug, induces DNA damage and apoptosis in HBV-positive hepatocellular carcinoma HepG2.2.15 cell.
    Liu Z, Li G, Gou Y, Xiao D, Luo G, Saavedra JE, Liu J, Wang H.
    Biomed Pharmacother; 2017 Aug 09; 92():989-997. PubMed ID: 28605880
    [Abstract] [Full Text] [Related]

  • 5. Exogenous NO induces apoptosis of hepatocellular carcinoma cells via positive p38/JNK signaling pathway and negative ERK signaling pathways.
    Liu L, Xing Y, Cao M, Xu J, Chen J.
    Mol Cell Biochem; 2021 Apr 09; 476(4):1651-1661. PubMed ID: 33420899
    [Abstract] [Full Text] [Related]

  • 6. JS-K as a nitric oxide donor induces apoptosis via the ROS/Ca2+/caspase-mediated mitochondrial pathway in HepG2 cells.
    Huang Z, Liu L, Chen J, Cao M, Wang J.
    Biomed Pharmacother; 2018 Nov 09; 107():1385-1392. PubMed ID: 30257354
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of CIP2A determines erlotinib-induced apoptosis in hepatocellular carcinoma.
    Yu HC, Chen HJ, Chang YL, Liu CY, Shiau CW, Cheng AL, Chen KF.
    Biochem Pharmacol; 2013 Feb 01; 85(3):356-66. PubMed ID: 23178652
    [Abstract] [Full Text] [Related]

  • 8. Apoptosis induced by protein phosphatase 2A (PP2A) inhibition in T leukemia cells is negatively regulated by PP2A-associated p38 mitogen-activated protein kinase.
    Boudreau RT, Conrad DM, Hoskin DW.
    Cell Signal; 2007 Jan 01; 19(1):139-51. PubMed ID: 16844342
    [Abstract] [Full Text] [Related]

  • 9. PPARalpha and PP2A are involved in the proapoptotic effect of conjugated linoleic acid on human hepatoma cell line SK-HEP-1.
    Muzio G, Maggiora M, Oraldi M, Trombetta A, Canuto RA.
    Int J Cancer; 2007 Dec 01; 121(11):2395-401. PubMed ID: 17691108
    [Abstract] [Full Text] [Related]

  • 10. Total alkaloids of Rubus aleaefolius Poir inhibit hepatocellular carcinoma growth in vivo and in vitro via activation of mitochondrial-dependent apoptosis.
    Zhao J, Chen X, Lin W, Wu G, Zhuang Q, Zhong X, Hong Z, Peng J.
    Int J Oncol; 2013 Mar 01; 42(3):971-8. PubMed ID: 23338043
    [Abstract] [Full Text] [Related]

  • 11. Synergistic interactions between sorafenib and bortezomib in hepatocellular carcinoma involve PP2A-dependent Akt inactivation.
    Chen KF, Yu HC, Liu TH, Lee SS, Chen PJ, Cheng AL.
    J Hepatol; 2010 Jan 01; 52(1):88-95. PubMed ID: 19913321
    [Abstract] [Full Text] [Related]

  • 12. Induction of apoptosis by the proteasome inhibitor MG132 in human HCC cells: Possible correlation with specific caspase-dependent cleavage of beta-catenin and inhibition of beta-catenin-mediated transactivation.
    Cervello M, Giannitrapani L, La Rosa M, Notarbartolo M, Labbozzetta M, Poma P, Montalto G, D'Alessandro N.
    Int J Mol Med; 2004 May 01; 13(5):741-8. PubMed ID: 15067380
    [Abstract] [Full Text] [Related]

  • 13. Effects of JS-K, a novel anti-cancer nitric oxide prodrug, on gene expression in human hepatoma Hep3B cells.
    Dong R, Wang X, Wang H, Liu Z, Liu J, Saavedra JE.
    Biomed Pharmacother; 2017 Apr 01; 88():367-373. PubMed ID: 28122301
    [Abstract] [Full Text] [Related]

  • 14. B4G2 induces mitochondrial apoptosis by the ROS-mediated opening of Ca(2+)-dependent permeability transition pores.
    Yao N, Li YJ, Zhang DM, Liu DL, Tang MK, Yiu A, Li Y, Chen WM, Lan P, Yao Z, Chen ZS, Ye WC.
    Cell Physiol Biochem; 2015 Apr 01; 37(3):838-52. PubMed ID: 26382946
    [Abstract] [Full Text] [Related]

  • 15. CIP2A mediates effects of bortezomib on phospho-Akt and apoptosis in hepatocellular carcinoma cells.
    Chen KF, Liu CY, Lin YC, Yu HC, Liu TH, Hou DR, Chen PJ, Cheng AL.
    Oncogene; 2010 Nov 25; 29(47):6257-66. PubMed ID: 20729919
    [Abstract] [Full Text] [Related]

  • 16. JS-K, a nitric oxide prodrug, induces cytochrome c release and caspase activation in HL-60 myeloid leukemia cells.
    Udupi V, Yu M, Malaviya S, Saavedra JE, Shami PJ.
    Leuk Res; 2006 Oct 25; 30(10):1279-83. PubMed ID: 16439016
    [Abstract] [Full Text] [Related]

  • 17. Pseudolaric acid B exhibits anti-cancer activity on human hepatocellular carcinoma through inhibition of multiple carcinogenic signaling pathways.
    Zhang H, Li JC, Luo H, Zhao L, Zhang ZD, Shen XF.
    Phytomedicine; 2019 Jun 25; 59():152759. PubMed ID: 31004883
    [Abstract] [Full Text] [Related]

  • 18. Corosolic acid analogue, a natural triterpenoid saponin, induces apoptosis on human hepatocarcinoma cells through mitochondrial pathway in vitro.
    Qu L, Zhang H, Yang Y, Yang G, Xin H, Ling C.
    Pharm Biol; 2016 Aug 25; 54(8):1445-57. PubMed ID: 26810384
    [Abstract] [Full Text] [Related]

  • 19. Effects of antioxidants and caspase-3 inhibitor on the phenylethyl isothiocyanate-induced apoptotic signaling pathways in human PLC/PRF/5 cells.
    Wu SJ, Ng LT, Lin CC.
    Eur J Pharmacol; 2005 Aug 22; 518(2-3):96-106. PubMed ID: 16054126
    [Abstract] [Full Text] [Related]

  • 20. JS-K, a glutathione S-transferase-activated nitric oxide donor with antineoplastic activity in malignant gliomas.
    Weyerbrock A, Osterberg N, Psarras N, Baumer B, Kogias E, Werres A, Bette S, Saavedra JE, Keefer LK, Papazoglou A.
    Neurosurgery; 2012 Feb 22; 70(2):497-510; discussion 510. PubMed ID: 21849924
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.